Nicholas D. Oakes
Integrative Pharmacology
AstraZeneca R&D Mölndal
Sweden
Name/email consistency: high
- Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes. Oakes, N.D., Thalén, P., Aasum, E., Edgley, A., Larsen, T., Furler, S.M., Ljung, B., Severson, D. Am. J. Physiol. Endocrinol. Metab. (2006)
- Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats. Oakes, N.D., Thalén, P., Hultstrand, T., Jacinto, S., Camejo, G., Wallin, B., Ljung, B. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2005)
- Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists. Oakes, N.D., Ljung, B., Camejo, G. J. R. Soc. Med (2002)
- Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Oakes, N.D., Thalén, P.G., Jacinto, S.M., Ljung, B. Diabetes (2001)